Staff turnover in EUR60,0061,080,91942,10831,102-
Staff turnover in EUR60,0061,080,91942,10831,102-
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)3.233.603.6437.514.04
Dividend per share-----
Basic earnings per share-2.063.63-1.89-1.59-1.65
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover9.8189.67.05.00.0
Operating income (EBIT)-69.0127.8-72.1-62.5-68.7
Earnings before taxes-63.8117.9-62.0-54.0-61.6
Annual net profit/ loss-63.8117.9-62.0-54.0-61.7
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets164.2254.8192.5154.396.9
Total fixed assets8.57.55.94.25.2
Total assets172.7262.3198.4158.5102.1
Liabilities
Total short-term liabilities46.917.314.410.811.0
Total long-term liabilities18.59.87.56.110.7
Total provisions6.72.65.14.98.1
Equity capital107.3235.2176.4141.680.3
Total liabilities172.7262.3198.4158.5102.1
Management:
Patrick Amstutz
Michael Tobias Stumpp
Alexander Zürcher
Laura Jeanbart
Michael Pitzner
Ph.D. Daniel Steiner
Philippe Legenne
Renate Gloggner
Robert Hendriks
Seth Lewis
Board:
Agnete Brunsvik Fredriksen
Dominik Höchli
Michael Vasconcelles
Vito Palombella
Clare Fisher
Sandipkumar S. Kapadia
William Burns
Shareholding in %:
BVF Partners LP 21.14
GAM Investment Management (Switzerland) AG 2.40
Michael Tobias Stumpp 1.79
Molecular Partners AG 8.67
Novartis AG 4.31
Patrick Amstutz 1.88
Pictet Asset Management SA 0.36
UBS Asset Management Switzerland AG 5.09
Zenito Oy 0.31
Zürcher Kantonalbank (Investment Management) 0.86
Freefloat 53.20
Address: Wagistrasse 14, 8952 Schlieren
T: +41-44-755-77-00
F: +
I: http://www.molecularpartners.com
E: [email protected]